Efficacy of BNT162b2 mRNA COVID-19 Vaccine Lower in Patients With CLL
Second study shows lower neutralizing antibody titers against SARS-CoV-2 after the first dose among elderly patients with multiple myeloma
SLNB, RT Not Tied to Better Outcomes in Older Women With Breast Cancer
Receipt of sentinel lymph node biopsy or radiotherapy not associated with improved locoregional recurrence-free or disease-free survival
COVID-19-Associated Cancer Screening Deficit Quantified in U.S.
Absolute deficit in screening estimated at 3.9, 3.8, and 1.6 million for breast, colorectal, and prostate cancers, respectively
Universal Multigene Panel Test in CRC IDs Heritable Mutations
Sequencing results from universal panel changed cancer treatment for roughly one in 10 colorectal cancer patients
More Parity in Breast Reconstruction Seen With Medicaid Expansion
Increases in breast reconstruction rates among non-Hispanic Black women associated with Medicaid expansion
Adding Aspirin May Up Risk for Patients on DOAC for A-Fib/VTE
Among patients with a-fib and/or VTE, about one-third received ASA in addition to a DOAC with no clear indication for ASA
Many Patients Prefer Stool-Based Colorectal Cancer Screening Tests
Multitarget stool DNA test, fecal immunochemical test, or guaiac-based fecal occult blood test preferred over colonoscopy
USPSTF: Evidence Lacking for Use of Vitamins for CVD, Cancer Prevention
Task force recommends against use of beta-carotene, vitamin E for prevention of cardiovascular disease or cancer in adults
12 Cases of CVST Reported for Ad26.COV2.S Vaccine in the U.S.
Time from vaccination to symptom onset varied from six to 15 days; initial presentation was headache in 11 cases
HPV Vaccination Rates Suboptimal Within Ages 9 to 12 Years
For most of the study period, higher rates of HPV vaccination initiation and up-to-date rates were seen for non-Hispanic Blacks, Hispanics
